Results 181 to 190 of about 785,669 (310)

Phase I Study of Yttrium-90 Radiolabeled M5A Anti-Carcinoembryonic Antigen Humanized Antibody in Patients with Advanced Carcinoembryonic Antigen Producing Malignancies. [PDF]

open access: yesCancer Biother Radiopharm, 2020
Akhavan D   +13 more
europepmc   +1 more source

Real‐World Effectiveness of Tildrakizumab in Biologic‐Naive Plaque Psoriasis: A Case Series

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Tildrakizumab is a selective interleukin‐23 p19 inhibitor approved for moderate‐to‐severe plaque psoriasis. Real‐world data, specifically in biologic‐naive patients, remains limited. Objectives To evaluate the real‐world effectiveness and safety of tildrakizumab 100 mg in biologic‐naive patients with moderate‐to‐severe plaque ...
Davindra Singh   +2 more
wiley   +1 more source

Correction: Development of a Humanized Antibody with High Therapeutic Potential against Dengue Virus Type 2. [PDF]

open access: yesPLoS Negl Trop Dis
Li PC   +8 more
europepmc   +1 more source

A Paper-based Immunofluorescent Device for the Detection of SARS-CoV-2 Humanized Antibody

open access: yes, 2021
Kasetsirikul S   +5 more
europepmc   +1 more source

Real World Use of the IL‐36 Receptor Antagonist Spesolimab: A Systematic Review and Analysis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Spesolimab, an interleukin‐36 receptor antagonist, is approved for the treatment and prevention of generalised pustular psoriasis (GPP) flares. Its use has increasingly been reported in real‐world settings for both GPP and other inflammatory dermatoses.
Sophia A. Mense   +4 more
wiley   +1 more source

Data‐Independent Acquisition Mass Spectrometry in Tumor Classification and Cancer Biomarker Research

open access: yesMass Spectrometry Reviews, EarlyView.
Abstract Cancer treatment is far from optimal also because current classification systems do not reflect the complex molecular status of the tumor and its phenotype in sufficient detail. To construct molecular tumor classifiers, omics tools provide complex molecular data reflecting many aspects from genotype to phenotype.
Jan Simonik   +3 more
wiley   +1 more source

Recent Advances (2023–2025) of Capillary Electrophoresis‐Mass Spectrometry (CE‐MS) for Top‐Down Proteomics

open access: yesMass Spectrometry Reviews, EarlyView.
ABSTRACT Top‐down proteomics (TDP) characterizes proteoforms in cells, tissues, and biofluids, in discovery mode and on a global scale, requiring analytical tools with high peak capacity for proteoform separation and high sensitivity for proteoform detection, given the extremely high proteoform complexity and wide proteoform concentration dynamic range.
Guijie Zhu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy